Opthea Ltd (OPT) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.460x

Based on the latest financial reports, Opthea Ltd (OPT) has a cash flow conversion efficiency ratio of 0.460x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-92.00 Million ≈ $-65.10 Million USD) by net assets (AU$-200.16 Million ≈ $-141.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Opthea Ltd to measure how much of total assets are equity-financed.

Opthea Ltd - Cash Flow Conversion Efficiency Trend (1991–2025)

This chart illustrates how Opthea Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Opthea Ltd (OPT) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Opthea Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Opthea Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Wooree Lighting Co.Ltd
KQ:037400
-0.060x
Seker Finansal Kiralama AS
IS:SEKFK
0.184x
HANHUA FNCL HLDG CO.H YC1
F:5HF
N/A
KB SPAC 6
KQ:208640
-0.119x
Titanium Sands Ltd
AU:TSL
-0.031x
Creative Media & Community Trust Corporation
NASDAQ:CMCT
-0.101x
Electronic City Indonesia Tbk
JK:ECII
-0.015x
Kuk Young G&M Co. Ltd
KQ:006050
0.009x

Annual Cash Flow Conversion Efficiency for Opthea Ltd (1991–2025)

The table below shows the annual cash flow conversion efficiency of Opthea Ltd from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see OPT stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$-201.07 Million
≈ $-142.27 Million
AU$-158.64 Million
≈ $-112.25 Million
0.789x -62.85%
2024-06-30 AU$-75.81 Million
≈ $-53.64 Million
AU$-161.02 Million
≈ $-113.93 Million
2.124x -89.58%
2023-06-30 AU$-8.79 Million
≈ $-6.22 Million
AU$-179.30 Million
≈ $-126.87 Million
20.391x +1546.31%
2022-06-30 AU$69.77 Million
≈ $49.37 Million
AU$-98.37 Million
≈ $-69.60 Million
-1.410x -316.10%
2021-06-30 AU$180.20 Million
≈ $127.50 Million
AU$-61.06 Million
≈ $-43.20 Million
-0.339x -166.36%
2020-06-30 AU$64.81 Million
≈ $45.86 Million
AU$-8.24 Million
≈ $-5.83 Million
-0.127x +83.63%
2019-06-30 AU$31.12 Million
≈ $22.02 Million
AU$-24.19 Million
≈ $-17.11 Million
-0.777x -48.80%
2018-06-30 AU$38.17 Million
≈ $27.01 Million
AU$-19.94 Million
≈ $-14.11 Million
-0.522x -370.79%
2017-06-30 AU$54.49 Million
≈ $38.56 Million
AU$-6.05 Million
≈ $-4.28 Million
-0.111x +54.86%
2016-06-30 AU$14.98 Million
≈ $10.60 Million
AU$-3.68 Million
≈ $-2.60 Million
-0.246x +18.54%
2015-06-30 AU$16.66 Million
≈ $11.79 Million
AU$-5.03 Million
≈ $-3.56 Million
-0.302x +28.69%
2014-06-30 AU$9.87 Million
≈ $6.98 Million
AU$-4.17 Million
≈ $-2.95 Million
-0.423x +1.23%
2013-06-30 AU$13.10 Million
≈ $9.27 Million
AU$-5.61 Million
≈ $-3.97 Million
-0.428x -23.41%
2012-06-30 AU$20.67 Million
≈ $14.62 Million
AU$-7.17 Million
≈ $-5.08 Million
-0.347x +14.02%
2011-06-30 AU$23.32 Million
≈ $16.50 Million
AU$-9.42 Million
≈ $-6.66 Million
-0.404x -44.72%
2010-06-30 AU$27.04 Million
≈ $19.13 Million
AU$-7.54 Million
≈ $-5.34 Million
-0.279x -32.46%
2009-06-30 AU$31.29 Million
≈ $22.14 Million
AU$-6.59 Million
≈ $-4.66 Million
-0.211x -475.98%
2008-06-30 AU$49.18 Million
≈ $34.80 Million
AU$-1.80 Million
≈ $-1.27 Million
-0.037x -105.73%
2007-06-30 AU$51.71 Million
≈ $36.59 Million
AU$32.97 Million
≈ $23.33 Million
0.638x +1028.75%
2006-06-30 AU$42.07 Million
≈ $29.77 Million
AU$-2.89 Million
≈ $-2.04 Million
-0.069x -20.11%
2005-06-30 AU$28.63 Million
≈ $20.26 Million
AU$-1.64 Million
≈ $-1.16 Million
-0.057x +2.50%
2004-06-30 AU$29.15 Million
≈ $20.63 Million
AU$-1.71 Million
≈ $-1.21 Million
-0.059x -31.10%
2002-06-30 AU$23.28 Million
≈ $16.47 Million
AU$-1.04 Million
≈ $-736.53K
-0.045x -7.66%
2001-06-30 AU$24.20 Million
≈ $17.12 Million
AU$-1.01 Million
≈ $-711.19K
-0.042x +87.30%
1997-06-30 AU$5.32 Million
≈ $3.77 Million
AU$-1.74 Million
≈ $-1.23 Million
-0.327x -3.21%
1996-06-30 AU$3.83 Million
≈ $2.71 Million
AU$-1.22 Million
≈ $-859.69K
-0.317x +2.21%
1995-06-30 AU$2.07 Million
≈ $1.47 Million
AU$-672.00K
≈ $-475.48K
-0.324x -44.64%
1994-06-30 AU$2.09 Million
≈ $1.48 Million
AU$-469.00K
≈ $-331.85K
-0.224x -3.14%
1993-06-30 AU$1.62 Million
≈ $1.14 Million
AU$-351.00K
≈ $-248.35K
-0.217x -32.60%
1992-06-30 AU$1.63 Million
≈ $1.15 Million
AU$-267.00K
≈ $-188.92K
-0.164x -7.51%
1991-06-30 AU$1.29 Million
≈ $914.88K
AU$-197.00K
≈ $-139.39K
-0.152x --

About Opthea Ltd

AU:OPT Australia Biotechnology
Market Cap
$11.62 Million
AU$16.42 Million AUD
Market Cap Rank
#26671 Global
#1237 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.60
All Time High
AU$3.47
About

Opthea Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States. The company's pipeline includes Sozinibercept, which is in phase 3 to treat wet age-related macular degeneration (Wet AMD), as well as in phase 2 to treat diabetic macular edema (DME).… Read more